文献速递泌尿生殖腹部介入CTMR

肾细胞癌:RENAL肾脏测量评分与PADUA评分及最大肿瘤直径对热消融后局部复发的预测比较

Renal Cell Carcinoma: Comparison of RENAL Nephrometry and PADUA Scores with Maximum Tumor Diameter for Prediction of Local Recurrence after Thermal Ablation.
PubMed 文献 · Radiology · 2016-11-22

该回顾性研究纳入207例患者共217个经活检证实的肾细胞癌肿瘤,评估RENAL评分、PADUA评分及最大肿瘤直径等指标对热消融后局部复发的预测能力。RENAL评分(HR 1.43,P=.003)和PADUA评分(HR 1.80,P<.0001)与复发显著相关,但区分度仅为差至中等(C值分别为0.68和0.75);最大肿瘤直径区分度最高(C=0.81),直径每增加1 cm复发风险估计增加198%。

要点

  • 最大肿瘤直径对热消融后局部复发的区分度优于RENAL和PADUA评分(C=0.81 vs 0.68和0.75)。
  • RENAL评分与复发显著相关(HR 1.43,P=.003),但区分度仅为差至中等(C=0.68)。
  • PADUA评分与复发显著相关(HR 1.80,P<.0001),区分度为中等(C=0.75)。

核心结论

  • 最大肿瘤直径在预测肾细胞癌热消融后局部肿瘤复发方面优于现有肿瘤评分系统及其他评估的肿瘤生物测量指标。

研究设计与样本

  • 回顾性评估207例连续患者(131名男性、76名女性;平均年龄71.9岁±10.9)共217个经活检证实的肾细胞癌肿瘤,均接受热消融治疗。
  • 符合HIPAA的研究,经机构审查委员会批准并豁免知情同意。
  • 采用系列消融后CT或MR成像评估局部肿瘤复发。
  • 由影像学肿瘤形态数据计算每例肿瘤的RENAL肾脏测量评分和PADUA评分,并测量最大肿瘤直径等其他肿瘤生物测量指标及其组合。
  • 采用Harrell C指数和风险回归技术量化各指标与局部肿瘤复发的关联。

诊断标准与关键数值

  • RENAL评分与复发显著相关(HR 1.43,P=.003),Harrell C指数为0.68。
  • PADUA评分与复发显著相关(HR 1.80,P<.0001),Harrell C指数为0.75。
  • 最大肿瘤直径在所有评估的单一变量中区分度最高(C=0.81),回归分析中显著预测复发(HR 2.98,P<.0001)。
  • 肿瘤直径每增加1 cm,估计复发风险率增加198%。

临床应用与阅片要点

  • 作者结论认为,最大肿瘤直径对肾细胞癌消融后局部肿瘤复发的预测性能优于现有肿瘤评分系统及其他评估的肿瘤生物测量指标。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate the performance of the radius, exophytic or endophytic, nearness to collecting system or sinus, anterior or posterior, and location relative to polar lines (RENAL) nephrometry and preoperative aspects and dimensions used for anatomic classification (PADUA) scoring systems and other tumor biometrics for prediction of local tumor recurrence in patients with renal cell carcinoma after thermal ablation. Materials and Methods This HIPAA-compliant study was performed with a waiver of informed consent after institutional review board approval was obtained. A retrospective evaluation of 207 consecutive patients (131 men, 76 women; mean age, 71.9 years ± 10.9) with 217 biopsy-proven renal cell carcinoma tumors treated with thermal ablation was conducted. Serial postablation computed tomography (CT) or magnetic resonance (MR) imaging was used to evaluate for local tumor recurrence. For each tumor, RENAL nephrometry and PADUA scores were calculated by using imaging-derived tumor morphologic data. Several additional tumor biometrics and combinations thereof were also measured, including maximum tumor diameter. The Harrell C index and hazard regression techniques were used to quantify associations with local tumor recurrence. Results The RENAL (hazard ratio, 1.43; P = .003) and PADUA (hazard ratio, 1.80; P < .0001) scores were found to be significantly associated with recurrence when regression techniques were used but demonstrated only poor to fair discrimination according to Harrell C index results (C, 0.68 and 0.75, respectively). Maximum tumor diameter showed the highest discriminatory strength of any individual variable evaluated (C, 0.81) and was also significantly predictive when regression techniques were used (hazard ratio, 2.98; P < .0001). For every 1-cm increase in diameter, the estimated rate of recurrence risk increased by 198%. Conclusion Maximum tumor diameter demonstrates superior performance relative to existing tumor scoring systems and other evaluated biometrics for prediction of local tumor recurrence after renal cell carcinoma ablation. © RSNA, 2016.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Maxwell AWP, Baird GL, Iannuccilli JD, et al. Renal Cell Carcinoma: Comparison of RENAL Nephrometry and PADUA Scores with Maximum Tumor Diameter for Prediction of Local Recurrence after Thermal Ablation. Radiology. 2016. PMID: 27875105. doi:10.1148/radiol.2016161225

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。